J. Hamann et al., THE 7-SPAN TRANSMEMBRANE RECEPTOR CD97 HAS A CELLULAR LIGAND (CD55, DAF), The Journal of experimental medicine, 184(3), 1996, pp. 1185-1189
CD97 is an activation-induced antigen on leukocytes with a seven-span
transmembrane (7-TM) region homologous to the secretin receptor superf
amily. However, in contrast to this group of peptide hormone receptors
, CD97 has an extended extracellular region with three EGF domains at
the NH2 terminus, two of them with a calcium binding site. By demonstr
ating that lymphocytes and erythrocytes specifically adhere to CD97-tr
ansfected COS cells we here show that CD97 in parallel with its molecu
lar evolution has acquired the ability to bind cellular ligands. A mAb
selected on its capacity to block the adhesion between CD97 transfect
ants and red cells was found to be directed to the NH2-terminal short
consensus repeat (SCR) of decay accelerating factor (DAF, CD55), a reg
ulatory protein of the complement cascade. The specificity of the inte
raction of CD97 with CD55 was established by the observation that eryt
hrocytes that lack CD55, obtained from patients with paroxysmal noctur
nal hemoglobinuria (PNH) or the CD55(-) phenotype Inab, failed to adhe
re to CD97 transfectants. This is the first demonstration of a cellula
r ligand for a 7-TM receptor.